CSBR:NASDAQ
Champions Oncology Inc
$4.70
arrow_upward
+1.18%(+0.055) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.57
High
$4.70
Low
$4.52
Mkt. cap
65.49M
Avg. vol.
8.16K
Volume
3.02K
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.57
High
$4.70
Low
$4.52
Mkt. cap
65.49M
Avg. vol.
8.16K
Volume
3.02K
52-wk high
$8.31
52-wk low
$4.52
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
BigGo Finance
·
1 hour ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
27 minutes ago
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
24/7 Wall St.
·
15 hours ago
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Longbridge
·
2 days ago
[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com